Axonics Modulation Technologies, Inc. (AXNX) financial statements (2020 and earlier)

Company profile

Business Address 26 TECHNOLOGY DRIVE
IRVINE, CA 92618
State of Incorp. DE
Fiscal Year End December 31
SIC 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

9/30/2019
TTM
12/31/2018
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments102158
Cash and cash equivalents7698
Short-term investments2559
Receivables10
Inventory, net of allowances, customer advances and progress billings134
Inventory134
Other undisclosed current assets34
Total current assets:118165
Noncurrent Assets
Property, plant and equipment33
Intangible assets, net (including goodwill)00
Intangible assets, net (excluding goodwill)00
Other noncurrent assets53
Total noncurrent assets:87
TOTAL ASSETS:126172
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities95
Accounts payable43
Accrued liabilities42
Debt7 
Other undisclosed current liabilities 1
Total current liabilities:166
Noncurrent Liabilities
Long-term debt and lease obligation1819
Long-term debt, excluding current maturities1419
Operating lease, liability5
Other undisclosed noncurrent liabilities 3
Total noncurrent liabilities:1823
Total liabilities:3429
Stockholders' equity
Stockholders' equity attributable to parent92143
Common stock00
Additional paid in capital250243
Accumulated other comprehensive loss(1)(0)
Accumulated deficit(157)(100)
Total stockholders' equity:92143
TOTAL LIABILITIES AND EQUITY:126172

Income statement (P&L) ($ in millions)

9/30/2019
TTM
12/31/2018
Revenues41
Cost of revenue
(Cost of Goods and Services Sold)
(2)(0)
Gross profit:20
Operating expenses(70)(32)
Operating loss:(67)(32)
Nonoperating income (expense)1(0)
Investment income, nonoperating31
Other nonoperating expense(3)(1)
Interest and debt expense(0)(0)
Other undisclosed loss from continuing operations before equity method investments, income taxes(0) 
Loss from continuing operations before equity method investments, income taxes:(67)(33)
Other undisclosed income from continuing operations before income taxes10
Loss from continuing operations before income taxes:(67)(32)
Income tax expense(0)(0)
Net loss available to common stockholders, diluted:(67)(32)

Comprehensive Income ($ in millions)

9/30/2019
TTM
12/31/2018
Net loss:(67)(32)
Comprehensive loss:(67)(32)
Other undisclosed comprehensive loss, net of tax, attributable to parent(0)(0)
Comprehensive loss, net of tax, attributable to parent:(67)(32)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: